Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms

The ability of monoclonal antibodies (mAbs) to target specific antigens with high precision has led to an increasing demand to generate them for therapeutic use in many disease areas. Historically, the discovery of therapeutic mAbs has relied upon the immunization of mammals and various in vitro dis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:MAbs
Autores principales: Abdiche, Yasmina Noubia, Harriman, Rian, Deng, Xiaodi, Yeung, Yik Andy, Miles, Adam, Morishige, Winse, Boustany, Leila, Zhu, Lei, Izquierdo, Shelley Mettler, Harriman, William
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966639/
https://ncbi.nlm.nih.gov/pubmed/26652308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2015.1118596
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares